Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Adrenomedullin in Early Diagnosis of Pancreatic Cancer in New Onset Diabetes Patients

NCT02456051 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT02456051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02456051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Adrenomedullin in Early Diagnosis of Pancreatic Cancer in New Onset Diabetes Patients
Lead sponsor
University of Roma La Sapienza
Phase
Observational
Overall status
Terminated
Start date
April 30, 2015
Completion date
November 30, 2017
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, pancreatic ductal, diabetes complications, diabetes mellitus, adult-onset, pancreatic neoplasm